Dialysis Market Size and CAGR by 2031
The Dialysis Market is expected to register a CAGR of 7.2% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Type (Hemodialysis, Peritoneal Dialysis). The report further presents analysis based on the Product & Services (Equipment, Consumables, Drugs, Services). The report is segmented by End User (In-center Dialysis, Home Dialysis). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Dialysis Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Dialysis Market Segmentation
Type- Hemodialysis
- Peritoneal Dialysis
- Equipment
- Consumables
- Drugs
- Services
- In-center Dialysis
- Home Dialysis
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Dialysis Market Growth Drivers- Increasing Prevalence of Chronic Kidney Disease (CKD): One of the key drivers in dialysis markets is an increasing incidence of chronic kidney disease. CKD has emerged as a global health issue, now affecting millions of people worldwide. The World Health Organization had faced the rising prevalence of CKD over the past several decades owing to causes such as the aging population, unhealthy lifestyles, and rapid growth in the number of diabetes and hypertension cases. In end-stage renal disease, patients often require dialysis therapy. To treat ever larger numbers of patients receiving dialysis therapy, the needs increase for dialysis service and dialysis machines as well as all the consumables. Increasingly large numbers of patients requiring dialysis therapy reflect an even greater need for effective, efficient treatments; hence investments in dialysis technologies and facilities also increase in light of this need.
- Technological Advancements in Dialysis Treatment: Another major impeller driving the dialysis market is technological innovation. Advanced development in dialysis technology has led to better outcomes in the treatment, comfort to patients, and increased access. Innovations, such as portable dialysis machines, wearable devices, and home dialysis solutions, are really revolutionizing the way patients undergo treatment. For example, Home Hemodialysis (HHD) and Peritoneal Dialysis (PD) have become the in-center alternative for many patients. These improvements not only upgrade the quality of a patient's life but also reduce the load on healthcare establishments. In addition, technologies of telehealth and remote monitoring help healthcare providers manage better care for patients and generally increase treatment efficiency.
- Government Initiatives and Reimbursement Policies: Government policies, added to the supportive reimbursement policies, are driving the dialysis market. It has been realized by many nations that untreated kidney diseases are an economic burden and need to be checked or detected at an early stage, thereby implementing policies to encourage early detection and start of treatments. For the same, funding of dialysis services is supported, along with incentive for home-based therapies. For instance, within the United States, the Centers for Medicare & Medicaid Services have developed a number of programs that have contributed to bettering kidney care. These include the End-Stage Renal Disease Quality Incentive Program. Such programs coincide with adequate financial support directed towards dialysis services and promoting the adoption of best practices in patient care, further accelerating the pace of market growth.
- Shift Toward Home Dialysis: One trend that is particularly visible in the dialysis market is home dialysis: patients are increasingly going to treatments based at home and offering them much greater flexibility and more convenient options, which results in increases in home hemodialysis and peritoneal dialysis. Some of these include improvements in the technological field, making it safer and more effective for home dialysis. Home dialysis also helps healthcare providers: The two major benefits are in terms of cost and patient satisfaction. As more patients opt for home-based treatment, there is going to be an extensive boost in the demand for home dialysis equipment and supplies in the near future.
- Focus on Patient-Centric Care: The present medical trend in the dialysis market is moving toward patient-centric care, with specific treatment plans and active patient involvement. Providers are slowly coming to realize that more patients want to be actively involved in making their decisions on care and treatment suited to their needs and preferences. The rising awareness in the quality of life for the patient with CKD are helping set this trend. There is a greater need now for value-based healthcare from dialysis care providers as they consider better management approaches in seeking and improving patient satisfaction and outcomes instead of merely providing delivery service.
- Emphasis on Preventive Care and Early Intervention: Preventive care and early intervention is burgeoning in the dialysis market. Healthcare providers aim at embracing strategies identifying at-risk people and fostering lifestyle changes that delay or can even reverse progression to CKD. Schemes primarily targeted at raising the awareness of kidney health and routine screening are gaining much acceptance. This shift toward prevention does not only favor the patient but also the healthcare systems through relieving certain financial burdens such as incidences of advanced kidney disease and treatments through dialysis reduce.
- Expansion into Emerging Markets: Emerging economies offer more opportunities for growth in the dialysis market. Improvement in healthcare infrastructure in regions like India, China, and Brazil is expected to propel growth in demand for dialysis. These regions account for the rising trend of lifestyle diseases, which have been correlated with an increasing prevalence of CKD. Companies that strategically invest in emerging markets would be able to access an enormous and largely underserved patient population base. Facilitations from local healthcare service providers, alongside government efforts, would ensure that dialysis services are made available, which makes treatment more affordable and widespread.
- Development of Innovative Dialysis Therapies: A new opportunity arises in innovative dialysis therapies, which would assist in overcoming the limitations posed by traditional approaches. Studies involving bioartificial kidneys, regenerative medicine, and new forms of dialysis will have an impact on higher efficacy treatment and reduced frequency sessions. Advancements in biocompatible materials and membrane technology can bring about a form of dialysis that is more effective and more patient: friendly. In increasingly competitive markets, such businesses can differentiate themselves and serve the changing needs of patients and healthcare providers by investing in R&D to create next: generation dialysis products.
- Integration of Artificial Intelligence and Data Analytics: AI- data analytics Integration in dialysis treatment presents to this market a bright opportunity for AI and data analytics. This is through advanced patient monitoring, complication predictions, and more individualized treatment for the patient, thus better outcomes in patient care. Data analytics would have opportunities to optimize resource deployment, improve operational efficiency, and enhance patient engagement among providers. As the healthcare sector continues to embrace its digital transformation, companies that integrate AI and data analytics with dialysis care can really cash in on an opportunity for enhanced patient experience and efficient operations into the future.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Dialysis Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Dialysis Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America region dominated the Dialysis market in 2023.
Drugs segment, by product & services, dominated the market in 2023.
Players operating in the market are General Electric, Hitachi Medical Systems, ESAOTE SPA, Koninklijke Philiips N.V., Canon Medical Systems Corporation, Altair Engineering, Inc., Revtek Solutions, MinFound Medical Systems, SternMed, and Time Medical Holding
The Dialysis Market is estimated to witness a CAGR of 7.2% from 202#to 2031
Development of Innovative Dialysis Therapies act as a opportunity for growth of the market in forecast period.
The major factors driving the Dialysis market are:
1. Technological Advancements in Dialysis Treatment
2.Government Initiatives and Reimbursement Policies
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dialysis Market - By Type
1.3.2 Dialysis Market - By Product & Services
1.3.3 Dialysis Market - By End User
1.3.4 Dialysis Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DIALYSIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIALYSIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DIALYSIS MARKET - GLOBAL MARKET ANALYSIS
6.1. DIALYSIS - GLOBAL MARKET OVERVIEW
6.2. DIALYSIS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DIALYSIS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HEMODIALYSIS
7.3.1. Overview
7.3.2. Hemodialysis Market Forecast and Analysis
7.3.3. Conventional Hemodialysis Market
7.3.3.1. Overview
7.3.3.2. Conventional Hemodialysis Market Forecast and Analysis
7.3.4. Short Daily Hemodialysis Market
7.3.4.1. Overview
7.3.4.2. Short Daily Hemodialysis Market Forecast and Analysis
7.3.5. Nocturnal Hemodialysis Market
7.3.5.1. Overview
7.3.5.2. Nocturnal Hemodialysis Market Forecast and Analysis
7.4. PERITONEAL DIALYSIS
7.4.1. Overview
7.4.2. Peritoneal Dialysis Market Forecast and Analysis
7.4.3. Continuous Ambulatory Peritoneal Dialysis (CAPD) Market
7.4.3.1. Overview
7.4.3.2. Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Forecast and Analysis
7.4.4. Automated Peritoneal Dialysis (APD) Market
7.4.4.1. Overview
7.4.4.2. Automated Peritoneal Dialysis (APD) Market Forecast and Analysis
8. DIALYSIS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT AND SERVICES
8.1. OVERVIEW
8.2. PRODUCT AND SERVICES MARKET FORECASTS AND ANALYSIS
8.3. EQUIPMENT
8.3.1. Overview
8.3.2. Equipment Market Forecast and Analysis
8.3.3. Dialysis Machines Market
8.3.3.1. Overview
8.3.3.2. Dialysis Machines Market Forecast and Analysis
8.3.4. Water Treatment Systems Market
8.3.4.1. Overview
8.3.4.2. Water Treatment Systems Market Forecast and Analysis
8.3.5. Others Market
8.3.5.1. Overview
8.3.5.2. Others Market Forecast and Analysis
8.4. CONSUMABLES
8.4.1. Overview
8.4.2. Consumables Market Forecast and Analysis
8.4.3. Dialyzers Market
8.4.3.1. Overview
8.4.3.2. Dialyzers Market Forecast and Analysis
8.4.4. Catheters Market
8.4.4.1. Overview
8.4.4.2. Catheters Market Forecast and Analysis
8.4.5. Others Market
8.4.5.1. Overview
8.4.5.2. Others Market Forecast and Analysis
8.5. DRUGS
8.5.1. Overview
8.5.2. Drugs Market Forecast and Analysis
8.6. SERVICES
8.6.1. Overview
8.6.2. Services Market Forecast and Analysis
9. DIALYSIS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. IN-CENTER DIALYSIS
9.3.1. Overview
9.3.2. In-center Dialysis Market Forecast and Analysis
9.4. HOME DIALYSIS
9.4.1. Overview
9.4.2. Home Dialysis Market Forecast and Analysis
10. DIALYSIS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Dialysis Market Overview
10.1.2 North America Dialysis Market Forecasts and Analysis
10.1.3 North America Dialysis Market Forecasts and Analysis - By Type
10.1.4 North America Dialysis Market Forecasts and Analysis - By Product and Services
10.1.5 North America Dialysis Market Forecasts and Analysis - By End User
10.1.6 North America Dialysis Market Forecasts and Analysis - By Countries
10.1.6.1 United States Dialysis Market
10.1.6.1.1 United States Dialysis Market by Type
10.1.6.1.2 United States Dialysis Market by Product and Services
10.1.6.1.3 United States Dialysis Market by End User
10.1.6.2 Canada Dialysis Market
10.1.6.2.1 Canada Dialysis Market by Type
10.1.6.2.2 Canada Dialysis Market by Product and Services
10.1.6.2.3 Canada Dialysis Market by End User
10.1.6.3 Mexico Dialysis Market
10.1.6.3.1 Mexico Dialysis Market by Type
10.1.6.3.2 Mexico Dialysis Market by Product and Services
10.1.6.3.3 Mexico Dialysis Market by End User
10.2. EUROPE
10.2.1 Europe Dialysis Market Overview
10.2.2 Europe Dialysis Market Forecasts and Analysis
10.2.3 Europe Dialysis Market Forecasts and Analysis - By Type
10.2.4 Europe Dialysis Market Forecasts and Analysis - By Product and Services
10.2.5 Europe Dialysis Market Forecasts and Analysis - By End User
10.2.6 Europe Dialysis Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Dialysis Market
10.2.6.1.1 Germany Dialysis Market by Type
10.2.6.1.2 Germany Dialysis Market by Product and Services
10.2.6.1.3 Germany Dialysis Market by End User
10.2.6.2 France Dialysis Market
10.2.6.2.1 France Dialysis Market by Type
10.2.6.2.2 France Dialysis Market by Product and Services
10.2.6.2.3 France Dialysis Market by End User
10.2.6.3 Italy Dialysis Market
10.2.6.3.1 Italy Dialysis Market by Type
10.2.6.3.2 Italy Dialysis Market by Product and Services
10.2.6.3.3 Italy Dialysis Market by End User
10.2.6.4 Spain Dialysis Market
10.2.6.4.1 Spain Dialysis Market by Type
10.2.6.4.2 Spain Dialysis Market by Product and Services
10.2.6.4.3 Spain Dialysis Market by End User
10.2.6.5 United Kingdom Dialysis Market
10.2.6.5.1 United Kingdom Dialysis Market by Type
10.2.6.5.2 United Kingdom Dialysis Market by Product and Services
10.2.6.5.3 United Kingdom Dialysis Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Dialysis Market Overview
10.3.2 Asia-Pacific Dialysis Market Forecasts and Analysis
10.3.3 Asia-Pacific Dialysis Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Dialysis Market Forecasts and Analysis - By Product and Services
10.3.5 Asia-Pacific Dialysis Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Dialysis Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Dialysis Market
10.3.6.1.1 Australia Dialysis Market by Type
10.3.6.1.2 Australia Dialysis Market by Product and Services
10.3.6.1.3 Australia Dialysis Market by End User
10.3.6.2 China Dialysis Market
10.3.6.2.1 China Dialysis Market by Type
10.3.6.2.2 China Dialysis Market by Product and Services
10.3.6.2.3 China Dialysis Market by End User
10.3.6.3 India Dialysis Market
10.3.6.3.1 India Dialysis Market by Type
10.3.6.3.2 India Dialysis Market by Product and Services
10.3.6.3.3 India Dialysis Market by End User
10.3.6.4 Japan Dialysis Market
10.3.6.4.1 Japan Dialysis Market by Type
10.3.6.4.2 Japan Dialysis Market by Product and Services
10.3.6.4.3 Japan Dialysis Market by End User
10.3.6.5 South Korea Dialysis Market
10.3.6.5.1 South Korea Dialysis Market by Type
10.3.6.5.2 South Korea Dialysis Market by Product and Services
10.3.6.5.3 South Korea Dialysis Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Dialysis Market Overview
10.4.2 Middle East and Africa Dialysis Market Forecasts and Analysis
10.4.3 Middle East and Africa Dialysis Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Dialysis Market Forecasts and Analysis - By Product and Services
10.4.5 Middle East and Africa Dialysis Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Dialysis Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Dialysis Market
10.4.6.1.1 South Africa Dialysis Market by Type
10.4.6.1.2 South Africa Dialysis Market by Product and Services
10.4.6.1.3 South Africa Dialysis Market by End User
10.4.6.2 Saudi Arabia Dialysis Market
10.4.6.2.1 Saudi Arabia Dialysis Market by Type
10.4.6.2.2 Saudi Arabia Dialysis Market by Product and Services
10.4.6.2.3 Saudi Arabia Dialysis Market by End User
10.4.6.3 U.A.E Dialysis Market
10.4.6.3.1 U.A.E Dialysis Market by Type
10.4.6.3.2 U.A.E Dialysis Market by Product and Services
10.4.6.3.3 U.A.E Dialysis Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Dialysis Market Overview
10.5.2 South and Central America Dialysis Market Forecasts and Analysis
10.5.3 South and Central America Dialysis Market Forecasts and Analysis - By Type
10.5.4 South and Central America Dialysis Market Forecasts and Analysis - By Product and Services
10.5.5 South and Central America Dialysis Market Forecasts and Analysis - By End User
10.5.6 South and Central America Dialysis Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Dialysis Market
10.5.6.1.1 Brazil Dialysis Market by Type
10.5.6.1.2 Brazil Dialysis Market by Product and Services
10.5.6.1.3 Brazil Dialysis Market by End User
10.5.6.2 Argentina Dialysis Market
10.5.6.2.1 Argentina Dialysis Market by Type
10.5.6.2.2 Argentina Dialysis Market by Product and Services
10.5.6.2.3 Argentina Dialysis Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DIALYSIS MARKET, KEY COMPANY PROFILES
12.1. ASAHI KASEI MEDICAL CO., LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. B. BRAUN MELSUNGEN AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAXTER
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. DIAVERUM
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. FRESENIUS MEDICAL CARE AG & CO. KGAA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MEDIVATORS INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NIPRO CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NIKKISO CO., LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MEDTRONIC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TORAY MEDICAL CO., LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Asahi Kasei Medical Co., Ltd.
2. B. Braun Melsungen AG
3. Baxter
4. DIAVERUM
5. Fresenius Medical Care AG & Co. KGaA
6. Medivators Inc.
7. Nipro Corporation
8. NIKKISO CO., LTD.
9. Medtronic
10. Toray Medical Co., Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.